When the US Preventive Services Task Force (USPSTF) updated its ovarian cancer screening recommendation in April, it wasn't the first time transvaginal ultrasonography (TVU) and serum tumor marker cancer antigen CA-125 came up short as screening tools for asymptomatic women. The task force issued a grade D recommendation in 1996 and 2004 and reaffirmed its decision in 2008, citing “fair evidence” that ovarian cancer screening had little effect on reducing mortality rates while it increased the risk of harm.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Graphic Jump Location
The US Preventive Services Task Force upheld its position that the most recent scientific evidence doesn't justify routinely screening asymptomatic women for ovarian cancer.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.